InvestorsHub Logo
Followers 62
Posts 7557
Boards Moderated 1
Alias Born 01/02/2003

Re: BioInvestor3 post# 386732

Friday, 08/19/2022 7:28:11 PM

Friday, August 19, 2022 7:28:11 PM

Post# of 426487
BIO..."Germany has been known to offer 50% or less".... Germany has a choice...They can choose to allow their patients to suffer a increased rate of CVD or pay what other EU countries have determined is a fair price for Vaskepa...Amarin has NO choice...They could not survive as a going concern with a 50% reduction in their price.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News